Schedule 10 minutes with our team to learn how you can join OpenMarkets.

The OpenMarkets Exchange is excited to welcome our newest healthcare equipment supplier, iMedrix. With their product, the KardioScreen, they have revolutionized how EKG’s are performed, allowing individuals to detect and prevent Cardiovascular disease by monitoring heart conditions from anywhere at any time.

Heart disease is the leading cause of death in the United States. According to the CDC, one person dies every 37 seconds in the United States from cardiovascular disease. The mortality rate for COVID-19 patients with an existing heart condition is far higher than the general public. There is now, more than ever, a need for an affordable, portable, and mobile ECG/EKG. KardioScreen is the answer. 

The need for a cart, gel, and printer is now being replaced with a pocket-sized device that can upload test results directly to the cloud. The KardioScreen can be used in a variety of settings including home health, aged care, public health screening, point of care, for hub and spoke, pharma analytics, ambulance/STEMI response and ICU monitoring.

KardioScreen uses Artificial Intelligence to create real-time alerts on acute events such as LVH, Atrial Fibrillation, Ventricular Fibrillation and Conduction Block Detection. Cloud access allows KardioScreen to connect patients with their remote cardiologists and allows for a quick diagnosis and treatment plan.

Now more than ever, residents need to continue being monitored by their Physicians from the comfort of their home, without having to be transported to an office, urgent care or hospital. With the KardioScreen, contact-free care is now a reality, allowing patients around the world to continue receiving the quality care they need despite the difficult limitations brought by the COVID-19 pandemic.

To learn more about the KardioScreen and receive quotes and information from iMedrix directly, sign-up or log-in to the OpenMarkets Exchange today at no cost.